Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
Mucosal Immunol. 2023 Apr;16(2):153-166. doi: 10.1016/j.mucimm.2023.01.007. Epub 2023 Feb 2.
Secondary bacterial pneumonia after influenza A virus (IAV) infection is the leading cause of hospitalization and death associated with IAV infection worldwide. Nontypeable Haemophilus influenzae (NTHi) is one of the most common causes of secondary bacterial pneumonia. Current efforts to develop vaccines against NTHi infection focus on inducing antibodies but are hindered by antigenic diversity among NTHi strains. Therefore, we investigated the contribution of the memory T helper type 17 (Th17) response in protective immunity against IAV/NTHi coinfection. We observed that even a mild IAV infection impaired the NTHi-specific Th17 response and increased morbidity and mortality compared with NTHi monoinfected mice. However, pre-existing memory NTHi-specific Th17 cells induced by a previous NTHi infection overcame IAV-driven Th17 inhibition and were cross-protective against different NTHi strains. Last, mice immunized with a NTHi protein that induced a strong Th17 memory response were broadly protected against diverse NTHi strains after challenge with coinfection. These results indicate that vaccination that limits IAV infection to mild disease may be insufficient to eliminate the risk of a lethal secondary bacterial pneumonia. However, NTHi-specific memory Th17 cells provide serotype-independent protection despite an ongoing IAV infection and demonstrate the advantage of developing broadly protective Th17-inducing vaccines against secondary bacterial pneumonia.
流感病毒 (IAV) 感染后继发细菌性肺炎是全球范围内与 IAV 感染相关的住院和死亡的主要原因。无乳链球菌 (NTHi) 是继发细菌性肺炎的最常见原因之一。目前,针对 NTHi 感染开发疫苗的努力集中在诱导抗体上,但由于 NTHi 菌株之间的抗原多样性而受到阻碍。因此,我们研究了记忆 T 辅助细胞 17(Th17)反应在针对 IAV/NTHi 混合感染的保护性免疫中的贡献。我们观察到,即使是轻度的 IAV 感染也会削弱 NTHi 特异性 Th17 反应,并导致与 NTHi 单感染小鼠相比发病率和死亡率增加。然而,先前 NTHi 感染诱导的先前存在的记忆性 NTHi 特异性 Th17 细胞克服了 IAV 驱动的 Th17 抑制作用,并对不同的 NTHi 菌株具有交叉保护作用。最后,用诱导强烈 Th17 记忆反应的 NTHi 蛋白免疫的小鼠在受到混合感染挑战后,可广泛抵抗多种 NTHi 菌株。这些结果表明,限制 IAV 感染为轻度疾病的疫苗接种可能不足以消除致命性继发性细菌性肺炎的风险。然而,尽管存在持续的 IAV 感染,NTHi 特异性记忆性 Th17 细胞仍提供非血清型依赖性保护作用,并证明了开发针对继发性细菌性肺炎的广泛保护性 Th17 诱导疫苗的优势。